Article

Zeiss debuts new generation of high-resolution fundus cameras

Two new non-mydriatic cameras from Carl Zeiss Meditec use a high-resolution optical chain, delivering enhanced retinal details for more effective detection and management of eye diseases.

Las Vegas-Two new non-mydriatic cameras from Carl Zeiss Meditec use a high-resolution optical chain, delivering enhanced retinal details for more effective detection and management of eye diseases.

The two models (VISUCAM 224/524) are backed by an internal 24 MP sensor, a newly designed optical system, and enhanced post-processing for fast imaging, the company said. Both models include fundus autofluorescence as a standard feature, as well as color and red-free to enhance visualization of different anatomic features.

 

In addition, the VISUCAM 524 will also offer fluorescein angiography and optional indocyanine green angiography for the assessment of vascular blood flow and leakage.

Both models are available in the United States, Canada, the European Union, and throughout Asia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.